— Know what they know.
Not Investment Advice

002653.SZ

Haisco Pharmaceutical Group Co., Ltd.
1W: -1.1% 1M: +5.8% 3M: -5.0% YTD: +3.2% 1Y: +61.6% 3Y: +129.7% 5Y: +216.0%
¥51.31 ($7.43)
+0.53 (+1.04%)
 
SHZ · Healthcare · Biotechnology · ¥56.9B
Smart Money Score
Watch 0
Insider
Congress
ETF Holdings
Key Statistics
Market Cap¥56.9B ($8.2B)
52W Range35.68-62.65
Volume2,818,337
Avg Volume3,689,714
Beta-0.06
Dividend¥0.14
Analyst Ratings
No analyst coverage
Company Info
CEOXiu Lian Fan
Employees5,337
SectorHealthcare
IndustryBiotechnology
IPO Date2012-01-17
Websitehaisco.com
No.17, Sanxiang Avenue
Shannan 856000
CN
86 89 3783 4870
About Haisco Pharmaceutical Group Co., Ltd.

Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. The company offers small-volume injections, freeze-dried powder injections, powder injections, large-volume injections, active pharmaceutical ingredient, etc. for various therapeutic fields, including anti-infective, digestive system, blood system, nervous system, parenteral nutrition, antibiotics, first aid, anesthetics, and tumor; and tablets, capsules, granules, and ointments in the fields of cardiovascular, anti-infection, digestive system, CNS system, diabetes, and hepatic diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms